- Home
- AMRN vs NKSH Comparison
AMRN vs NKSH Comparison
Compare AMRN & NKSH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | AMRN | NKSH |
|---|---|---|
| Founded | 1989 | 1891 |
| Country | Ireland | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 339.8M | 185.2M |
| IPO Year | 1993 | N/A |
Fundamental Metrics
Financial Performance| Metric | AMRN | NKSH |
|---|---|---|
| Price | $14.36 | $32.95 |
| Analyst Decision | Strong Sell | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $12.00 | N/A |
| AVG Volume (30 Days) | ★ 80.9K | 12.5K |
| Earning Date | 10-29-2025 | 01-22-2026 |
| Dividend Yield | N/A | ★ 4.49% |
| EPS Growth | N/A | ★ 41.35 |
| EPS | N/A | ★ 2.04 |
| Revenue | ★ $226,733,000.00 | $51,980,000.00 |
| Revenue This Year | N/A | $2.95 |
| Revenue Next Year | N/A | $9.97 |
| P/E Ratio | ★ N/A | $16.45 |
| Revenue Growth | N/A | ★ 19.63 |
| 52 Week Low | $7.08 | $23.75 |
| 52 Week High | $20.90 | $33.92 |
Technical Indicators
Market Signals| Indicator | AMRN | NKSH |
|---|---|---|
| Relative Strength Index (RSI) | 35.29 | 73.37 |
| Support Level | $13.64 | $29.79 |
| Resistance Level | $14.67 | $30.72 |
| Average True Range (ATR) | 0.74 | 0.92 |
| MACD | -0.15 | 0.40 |
| Stochastic Oscillator | 24.21 | 96.46 |
Price Performance
Historical ComparisonAbout AMRN Amarin Corporation plc
Amarin Corp PLC is a biopharmaceutical company. It is focused on the commercialization and development of therapeutics to improve cardiovascular, or CV, health and reduce CV risk. Its commercialized product includes Vascepa.
About NKSH National Bankshares Inc.
National Bankshares Inc is a bank holding company. It focuses on lending to small and mid-sized businesses and individuals. The types of loans it offers include commercial and agricultural, commercial real estate, construction for commercial and residential properties, residential real estate, home equity, and various consumer loan products. It also operates an insurance and brokerage subsidiary, National Bankshares Financial Services, Inc. The company earns its revenues from interest and fees on loans, non-interest income, and investments.